Antibiotice proposed the distribution of the 2024 net profit, setting the gross dividend of 0.0206 DPS, which implies DY 0.85%.

Antibiotice S.A. proposed the distribution of its 2024 net profit of RON 102.2 million. A total of RON 13.8m will be allocated for dividends, with a gross dividend per share of RON 0.0206, calculated based on the current share capital of 671.3 million shares, which impliesa a 13.5% payout ratio.

The ex-dividend date is yet to be confirmed, while dividend payments will begin on 8 October 2025. The remainder of the profit is primarily allocated to tax-exempt reserves (RON 81.2m) and internal financing sources to support projects co-financed by external loans.

The Ministry of Health, as the majority shareholder (53.02%), would receive RON 7.3 million, while minority shareholders would receive RON 6.5 million. Dividend tax will be withheld at source in line with Romanian fiscal regulations.

Approval of this proposal is set for April 15 2025.